Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001332257 | SCV001524514 | uncertain significance | Factor H deficiency | 2020-09-15 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Revvity Omics, |
RCV003145578 | SCV003831613 | uncertain significance | not provided | 2019-12-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449943 | SCV004177421 | uncertain significance | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003456221 | SCV004177422 | uncertain significance | Age related macular degeneration 4 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003449944 | SCV004177423 | uncertain significance | Basal laminar drusen | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001332257 | SCV004177424 | uncertain significance | Factor H deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing |